When you're diagnosed with age-related macular degeneration, the stage of your disease matters. It shapes your treatment plan and how closely you're monitored. But what if different eye specialists looking at the same scans label the disease differently? That inconsistency can create confusion for patients and complicate research.
A team developed a new classification system called SOAC, designed to be used with a common type of detailed eye scan (optical coherence tomography). They tested it on scans from 108 patients. The key finding was that when different graders used this new system, they showed excellent agreement on how to stage the disease. This is a promising first step toward a shared, objective language for describing AMD.
It's important to understand what this study is and isn't. Right now, it only shows that trained graders can use the system consistently. We don't know yet if this classification accurately predicts how a patient's vision will change over time, or if it's better than other methods. The study didn't follow patients to see what happened to them. This is the beginning of validating a tool, not proof that it improves care.